|
Volumn 2, Issue 6, 2016, Pages a001180-
|
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
multifocal breast carcinoma; neoplasm of the gastrointestinal tract
|
Indexed keywords
CD274 PROTEIN, HUMAN;
GATA3 PROTEIN, HUMAN;
JAK2 PROTEIN, HUMAN;
JANUS KINASE 2;
KRAS PROTEIN, HUMAN;
PROGRAMMED DEATH 1 LIGAND 1;
PROTEIN P21;
TRANSCRIPTION FACTOR GATA 3;
TUMOR MARKER;
ADULT;
CANCER OF UNKNOWN PRIMARY SITE;
CANCER STAGING;
CLINICAL DECISION MAKING;
FEMALE;
GENE EXPRESSION PROFILING;
GENETICS;
GENOMICS;
HIGH THROUGHPUT SEQUENCING;
HUMAN;
METABOLISM;
MUTATION;
PATHOLOGY;
PROCEDURES;
TRIPLE NEGATIVE BREAST CANCER;
ADULT;
B7-H1 ANTIGEN;
BIOMARKERS, TUMOR;
CLINICAL DECISION-MAKING;
FEMALE;
GATA3 TRANSCRIPTION FACTOR;
GENE EXPRESSION PROFILING;
GENOMICS;
HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING;
HUMANS;
JANUS KINASE 2;
MUTATION;
NEOPLASM STAGING;
NEOPLASMS, UNKNOWN PRIMARY;
PROTO-ONCOGENE PROTEINS P21(RAS);
TRIPLE NEGATIVE BREAST NEOPLASMS;
|
EID: 85016647879
PISSN: 23732873
EISSN: None
Source Type: Journal
DOI: 10.1101/mcs.a001180 Document Type: Article |
Times cited : (55)
|
References (0)
|